AngioDynamics, Inc.
ANGO
$9.22
$0.111.21%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 292.50M | 283.32M | 286.50M | 292.73M | 303.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 292.50M | 283.32M | 286.50M | 292.73M | 303.91M |
| Cost of Revenue | 134.79M | 129.32M | 135.49M | 141.36M | 149.22M |
| Gross Profit | 157.71M | 154.00M | 151.01M | 151.36M | 154.70M |
| SG&A Expenses | 145.60M | 143.91M | 143.86M | 142.58M | 144.18M |
| Depreciation & Amortization | 10.32M | 10.30M | 10.99M | 11.99M | 13.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 316.56M | 309.55M | 317.68M | 325.55M | 337.76M |
| Operating Income | -24.06M | -26.23M | -31.18M | -32.83M | -33.84M |
| Income Before Tax | -34.03M | -42.06M | -237.39M | -239.16M | -191.64M |
| Income Tax Expenses | -39.00K | -671.00K | -12.67M | 3.87M | -7.29M |
| Earnings from Continuing Operations | -33.99 | -41.39 | -224.72 | -243.03 | -184.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.99M | -41.39M | -224.72M | -243.03M | -184.35M |
| EBIT | -24.06M | -26.23M | -31.18M | -32.83M | -33.84M |
| EBITDA | -1.66M | -1.85M | -5.60M | -7.42M | -8.53M |
| EPS Basic | -0.83 | -1.02 | -5.58 | -6.04 | -4.57 |
| Normalized Basic EPS | -0.28 | -0.30 | -0.46 | -0.49 | -0.51 |
| EPS Diluted | -0.84 | -1.02 | -5.58 | -6.04 | -4.58 |
| Normalized Diluted EPS | -0.28 | -0.30 | -0.46 | -0.49 | -0.51 |
| Average Basic Shares Outstanding | 163.41M | 162.86M | 162.24M | 161.53M | 160.72M |
| Average Diluted Shares Outstanding | 163.41M | 162.86M | 162.24M | 161.53M | 160.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |